Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REAL-GREFFE: Immune Regulation in Allogeneic HSCT
NCT03357172Recruiting
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Oct 2019
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Proportions of regulatory immune cells in peripheral blood at 2 years. Started Oct 2019; status: recruiting.
Beyond the preview
Go deeper on NCT03357172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03357172.